Precision Medicine of Hepatobiliary and Pancreatic Cancers: Focusing on Clinical Trial Outcomes

SIMPLE SUMMARY: Recently, tumor-agnostic precision medicine employing comprehensive genome profiling (CGP) and using next-generation sequencing (NGS) has been progressing. This review focuses on the recent progress in precision medicine for advanced unresectable hepatobiliary and pancreatic cancers....

Descripción completa

Detalles Bibliográficos
Autores principales: Tsumura, Takehiko, Doi, Keitaro, Marusawa, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367472/
https://www.ncbi.nlm.nih.gov/pubmed/35954337
http://dx.doi.org/10.3390/cancers14153674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367472/
https://www.ncbi.nlm.nih.gov/pubmed/35954337
http://dx.doi.org/10.3390/cancers14153674

Ejemplares similares